CESAR

Right tool, right job: deciding when to not use an AI tool

From searching and screening to drafting text, artificial intelligence (AI) tools offer the promise of increased efficiency. But with promise comes responsibility. Ella Flemyng, Cochrane’s Head of Editorial Policy and Research Integrity, highlights what you need to consider when deciding whether to use an AI tool, and when you might decide not to.

What makes Cochrane’s new AI study innovative?

Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.

Cochrane announces selected AI tools for innovative platform study

Cochrane has confirmed the two artificial intelligence (AI) tools selected to take part in our innovative platform study evaluating how artificial intelligence could support and enhance key stages of evidence synthesis.

How did Cochrane select AI tools to evaluate in our platform study?

Cochrane has launched an innovative study to test whether artificial intelligence tools can support or enhance evidence synthesis. We only have scope to evaluate two, and so a selection process was required. Here, we outline that process and demonstrate what Cochrane values when deciding whether to use an AI tool for evidence synthesis.

Cochrane launches innovative study to assess AI tools for evidence synthesis

Cochrane has launched a study to test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. The initiative will use an innovative platform study design and will adhere to robust and responsible criteria, upholding Cochrane’s rigorous standards for evidence.